Long lasting clinical response to chemotherapy for advanced uterine leiomyosarcoma: a case report

INTRODUCTION: Uterine leiomyosarcoma is one of the most frequent uterine sarcomas. In the metastatic setting it is sensitive to doxorubicin, ifosfamide, gemcitabine, docetaxel and a few other drugs, but time to progression is generally short. For this reason prognosis is often poor and there are few...

Descripción completa

Detalles Bibliográficos
Autores principales: Ridolfi, Claudio, Pasini, Giuseppe, Drudi, Fabrizio, Barzotti, Eleonora, Santelmo, Carlotta, Polselli, Antonio, Ravaioli, Alberto
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2013
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3565880/
https://www.ncbi.nlm.nih.gov/pubmed/23347560
http://dx.doi.org/10.1186/1752-1947-7-29

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3565880/
https://www.ncbi.nlm.nih.gov/pubmed/23347560
http://dx.doi.org/10.1186/1752-1947-7-29

Ejemplares similares